The novel therapy of the medication represents a major breakthrough in the care of type 2 diabetes. Distinct from existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide606436.blogunok.com/42266768/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment